ArticleCancer diagnosis & prognosis
The Effect of Malnutrition on Treatment Efficacy and Toxicity in Geriatric Patients Treated With Immune Checkpoint Inhibitors.
Article in Cancer diagnosis & prognosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Aim: Immune checkpoint inhibitors (ICIs) have been shown to be effective in various cancer subtypes and their use in clinical practice has become widespread in recent years. However, discussions on their effectiveness in geriatric patients and in cases of malnutrition are still ongoing. The aim of the study was to evaluate the association of geriatric nutritional index (GNRI) detected malnutrition risk with progression-free survival (PFS) and immune related adverse events (irAEs) in geriatric solid tumor patients treated with ICIs. Patients and Methods: The study was conducted retrospectively and included patients with metastatic solid tumors who received second- or third-line immunotherapy between 2018 and 2024 at the Dr. Abdurrahman Yurtaslan, Ankara Oncology Education and Research Hospital and Etlik City Hospital. The GNRI score of the patients at the start of immunotherapy was calculated, and the relationship between the GNRI score and PFS and irAEs was evaluated. Results: No significant association was found between sex ( Conclusion: Geriatric solid tumor patients are not fully represented in prospective clinical drug trials. Prospective studies are needed in which only geriatric patients are included, treatment efficacy and toxicity are assessed stepwise according to nutritional status, and malnutrition is treated to increase treatment efficacy and reduce toxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.